Stocks to Buy

Identifying winning stocks requires more than scanning headlines. InvestorPlace analysts focus on long-term themes, market timing, and structural shifts shaping where capital is flowing next, highlighting stocks positioned to benefit from those trends.

Raytheon Stock Could Be Worth 25% More Based on Raytheon’s Guidance

Raytheon Technologies looks cheap from an absolute and historical perspective. RTX stock could be worth up to 25% more at $126.51 using Raytheon's own guidance as well as historical metrics.

Snap Inc Stock Is Still Worth Fighting for in the Long Run

SNAP stock is at the forefront of one of the strongest trends in decades: Snap Inc has a leading role in creating our new metaverse.

Kodak Seems Reinvigorated and Is Worth a Look

KODK stock is making a turnaround bid. Here's what to watch for as its prices move upward and it becomes relevant.

T-Mobile Team-Up Just Gave You Another Reason to Invest in Disney

Don't be tempted to divest your DIS stock due to concerns in China, as theme parks are just part of Disney's modern business model.

Is Robinhood Stock Finally a Buy?

HOOD stock has seen a recent spike in price after announcing longer trading hours. Robinhood may finally have found a bottom.

3 Streaming Stocks That Are Screaming Buys Right Now

The share prices of these streaming stocks have been beaten down, but they provide attractive buying opportunities at current levels.

7 Fintech Stocks Set to Rise from the Ashes After PayPal Plunge

Fintechs are dirt cheap while established credit card and banks are fintechs in disguise that offer the best upside after shares fell.

It’s Time to Get Clinical, Not Cynical, With Ocugen Stock

The selling pressure on OCGN stock has been as heavy as a rock, but worried shareholders should celebrate Ocugen's breakthrough moments.

3 Top Cybersecurity Stocks to Buy Now

Cybersecurity stocks are getting increased attention as the war in Ukraine unnerved many companies regarding possible cyber attacks.

Opendoor’s iBuying Dominance Makes OPEN Stock a Bargain Under $10

Opendoor Technologies is the leader in iBuying, and OPEN stock will likely reflect that leadership in the coming quarters.

$18 Is the Next Target for Gevo Stock as Big Purchase Orders Come In

Big-money contracts for sustainable aviation fuel should finally get GEVO stock to well-deserved higher price points in 2022.

Novavax Stock Is a Bet on Interest From Unvaccinated People

NVAX stock represents a vaccine that lacks approval. There is real appeal behind the narrative, as it may appeal to unvaccinated people.

Teladoc Health Is a Cathie Wood Stock That You Need Now

TDOC stock is under selling pressure, but fast-growing revenue and a team-up with an e-commerce giant should put Teladoc back on track.

7 Blue-Chip Stocks With Dividends to Add to Your Buy List

Fed rate hikes have investors looking to reduce market risk and find consistent shareholder value. These blue-chip stocks offer robust dividend yields with a consistent record of payouts.

Alphabet Stock: The Conservative Choice for Cloud Investors

Alphabet is an unstoppable profit machine, and GOOG stock is a conservative play for conservative investors who want steady capital gains.

It’s a Good Idea to Buy Amazon Stock Before the Share Split

If you feel that AMZN stock has gotten too pricey, get ready for the floodgates to open as a major event will bring investors into the fold. Multi-billion-dollar share buyback plans underscore the upside potential of AMZN stock.

The 7 Most Undervalued Stocks to Buy in April

These are the seven most undervalued stocks to consider purchasing as we head into April in consideration of a complex, troubled economy.

Battery Technology Could Give Mullen Automotive the Charge It Needs

Mullen is making a wise business choice by offering strong EVs at a reasonable price. MULN stock is likely ready to stage a serious comeback.

Investors Seek Second Act with Moderna Stock

Moderna hopes its combination vaccine for COVID and the flu can keep profits high but investors are skeptical. MRNA stock struck gold with its Covid-19 vaccine but investors want to know if there are any other blockbusters in its pipeline.